Related Experiment Video
Updated: Dec 29, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents
Xiaoyue Wen1, Yongqin Zhou1, Junhao Zeng1
1The Institute of Infection and Inflammation, China Three Gorges University, Yichang, Hubei 443000, China.
1,2,4-Triazole compounds show significant anticancer potential. This review highlights recent advances in these molecules, discussing their structure-activity relationships and mechanisms for developing new cancer therapies.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Organic Chemistry
Background:
- 1,2,4-Triazole derivatives are recognized for their potent anticancer properties.
- Existing anticancer drugs incorporate the 1,2,4-triazole scaffold, underscoring its therapeutic relevance.
- This moiety is crucial in the design of novel anticancer agents.
Purpose of the Study:
- To review recent advancements in 1,2,4-triazole-containing compounds with anticancer potential.
- To explore the structure-activity relationships (SAR) of these compounds.
- To discuss their mechanisms of action in cancer treatment.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of structure-activity relationships of identified 1,2,4-triazole derivatives.
- Discussion of reported mechanisms of action for anticancer activity.
Main Results:
- Numerous 1,2,4-triazole derivatives exhibit significant in vitro and in vivo anticancer activity.
- Key structural features contributing to anticancer efficacy have been identified.
- Diverse mechanisms of action are associated with these compounds.
Conclusions:
- 1,2,4-Triazole derivatives represent a promising class of compounds for novel anticancer drug development.
- Understanding SAR and mechanisms of action is vital for optimizing therapeutic potential.
- Further research into these compounds could lead to effective cancer treatments.
More Related Videos
10:42Preparation of N-2-alkoxyvinylsulfonamides from N-tosyl-1,2,3-triazoles and Subsequent Conversion to Substituted Phthalans and Phenethylamines
Published on: January 3, 2018
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Drugs that Destabilize Microtubules